Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raman Bahal

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Current Opinion in Toxicology|May 16, 2023
Nephrotoxicity of marketed antisense oligonucleotide drugsHangyu Wu, Aniket Wahane, Feryal Alhamadani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 16, 2026
Impact of ionizable lipid source on quality and stability of siRNA-loaded lipid nanoparticlesSheyda Ranjbar, Kuo-Chih Shih, Andre O'Reilly Beringhs, et al.
Current Gene Therapy|September 2, 2014
Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognitionRaman Bahal, Elias Quijano, Nicole A McNeer, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer TherapyAnisha Gupta, Elias Quijano, Yanfeng Liu, et al.
Molecular Therapy. Nucleic Acids|February 3, 2026
Engineered miR-122 inhibitors preserve endothelial mitochondrial function and prevent vascular dysfunction in obesity-associated prediabetesRavinder Reddy Gaddam, Mounika Pathuri, Paroma Deb, et al.
Scientific Reports|June 24, 2020
Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db miceRavinder Reddy Gaddam, Veronica Peotta Jacobsen, Young-Rae Kim, et al.
Biomaterials|February 26, 2019
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastomaYoung-Eun Seo, Hee-Won Suh, Raman Bahal, et al.
Nature|November 20, 2014
MicroRNA silencing for cancer therapy targeted to the tumour microenvironmentChristopher J Cheng, Raman Bahal, Imran A Babar, et al.
Nature Communications|April 28, 2015
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epitheliumNicole Ali McNeer, Kavitha Anandalingam, Rachel J Fields, et al.
Pharmacological Reviews|September 11, 2023
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver OriginAnagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Current Opinion in Toxicology|May 16, 2023
Nephrotoxicity of marketed antisense oligonucleotide drugsHangyu Wu, Aniket Wahane, Feryal Alhamadani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 16, 2026
Impact of ionizable lipid source on quality and stability of siRNA-loaded lipid nanoparticlesSheyda Ranjbar, Kuo-Chih Shih, Andre O'Reilly Beringhs, et al.
Current Gene Therapy|September 2, 2014
Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognitionRaman Bahal, Elias Quijano, Nicole A McNeer, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer TherapyAnisha Gupta, Elias Quijano, Yanfeng Liu, et al.
Molecular Therapy. Nucleic Acids|February 3, 2026
Engineered miR-122 inhibitors preserve endothelial mitochondrial function and prevent vascular dysfunction in obesity-associated prediabetesRavinder Reddy Gaddam, Mounika Pathuri, Paroma Deb, et al.
Scientific Reports|June 24, 2020
Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db miceRavinder Reddy Gaddam, Veronica Peotta Jacobsen, Young-Rae Kim, et al.
Biomaterials|February 26, 2019
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastomaYoung-Eun Seo, Hee-Won Suh, Raman Bahal, et al.
Nature|November 20, 2014
MicroRNA silencing for cancer therapy targeted to the tumour microenvironmentChristopher J Cheng, Raman Bahal, Imran A Babar, et al.
Nature Communications|April 28, 2015
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epitheliumNicole Ali McNeer, Kavitha Anandalingam, Rachel J Fields, et al.
Pharmacological Reviews|September 11, 2023
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver OriginAnagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pageof 8